OBn
O
Footnotes
OH
BnO
BnO
* E-mail: panza@imiucca.csi.unimi.it
CO2Me
i
† All new compounds gave satisfactory elemental analysis and specroscopic
data. Selected data: [a]D: 2, 25.3 (c 0.8, CHCl3); 3: 45.6 (c 1.0, CHCl3); 4,
4.5 (c 0.9, CHCl3); 5, 5.4 (c 1.0, CHCl3); 6, 8.9 (c 1.0, CHCl3); 7, 28.1 (c
1.0, MeOH); 8, 16.4 (c 1.0, CHCl3). 1H NMR (CDCl3): 2, 5.96 (dd, 1 H, J
17.5, 10.8 Hz, H-2), 5.60 (dd, 1 H, J 17.5, 1.7 Hz, H-1a), 5.30 (dd, 1 H, J
10.8, 1.7 Hz, H-1b), 4.22 (t, 1 H, J 9.5 Hz, H-5), 4.10 and 4.02 (2 d, 2 H, J
16.1 Hz, CH2CO2Me), 3.72 (s, 3 H, Me), 3.42 (d, 1 H, J 9.5 Hz, H-4); 3, 4.94
(t, 1 H, J 7.4 Hz, H-4), 4.26 (br t, 1 H, J 5.1 Hz, H-2), 3.91 (d, 1 H, J 5.7 Hz,
H-6), 3.71 (s, 3 H, Me), 2.94 (br s, 1 H, OH), 2.67–2.58 (m, 2 H, H-3); 4,
4.18 (dd, 1 H, J 7.5, 4.4 Hz, H-2), 3.72 (s, 3 H, Me), 3.27 (m, 1 H, H-5), 3.04
(br s, 1 H, OH), 2.03 (m, 1 H, H-4a), 1.88 (m, 2 H, H-3), 1.57 (m, 1 H, H-4b);
5, 5.04 (dt, 1 H, J 7.7, 4 Hz, H-2), 3.65 (s, 3 H, Me), 3.18 (m, 1 H, H-5), 2.15
(m, 1 H, H-3a), 1.93 (m, 2 H, H-3b and H-4a), 1.57 (m, 1 H, H-4b); 6, 3.94
(dd, 1 H, J 8.8, 4.6 Hz, H-2), 3.74 (s, 3 H, Me), 3.26 (m, 1 H, H-5), 2.03 (m,
1 H, H-3a), 1.81 (m, 2 H, H-3b and H-4a), 1.56 (m, 1 H, H-4b); 7 (D2O,
50 °C), 4.39 (t, 1 H, J 6.3 Hz, H-2), 4.02 (s, 3 H, Me), 3.48 (m, 1 H, H-5),
2.38 (m, 1 H, H-3a), 2.21 (m, 2 H, H-3b and H-4a), 1.73 (m, 1 H, H-4b); 8,
5.14 (t, 1 H, J 9.5 Hz, H-7), 5.01 (t, 1 H, J 9.5 Hz, H-8), 4.85 (t, 1 H, J 9.5
Hz, H-6), 4.18 (dd, 1 H, J 12.4, 5.2 Hz, H-10a), 4.08 (dd, 1 H, J 12.4, 2.3
Hz, H-10b), 3.89 (dd, 1 H, J 8.8, 4.5 Hz, H-2), 3.77 (s, 3 H, Me), 3.60 (ddd,
1 H, J 9.5, 5.2, 2.3 Hz, H-9), 3.42 (dt, 1 H, J 9.5, 2.4 Hz, H-5), 2.1–1.9 (m,
13 H, H-3a and 4 Ac), 1.8–1.6 (m, 2 H, H-3b and H-4a), 1.57 (m, 1 H,
H-4b).
BnO
O
4
OBn
O
OP(OPh)2
i, ii
BnO
BnO
CO2Me
BnO
ii
OBn
O
5
7
N3
BnO
BnO
CO2Me
iii
OH
O
BnO
6
8
NH2•HCl
CO2Me
HO
HO
iv
OAc
O
HO
N3
AcO
AcO
CO2Me
AcO
Scheme 3 Reagents and conditions: i, DPPA, DBU, toluene; ii, Bu4NN3,
toluene; iii, H2, Pd(OH)2, EtOH, quant.; iv, Ac2O, Me3SiOSO2CF3, 67%
‡ By irradiation of the vinylic hydrogen, an NOE of 4.5% was observed on
the hydrogen atom at C-6 for compound 3.
Bu4NN3 in toluene gave the desired substitution product 6 in
88% yield. The reaction conditions were then modified as
follows to obtain a one-pot transformation: the phosphate ester
was formed as described above, but with heating to 55 °C. Then
a solution of Bu4NN310 (3 equiv., 0.2 m solution in toluene) was
added and the mixture was stirred at the same temperature until
the phosphate ester disappeared on TLC: in this way the desired
azido ester 6 was obtained in 92% yield.§
Reduction of the azido group and contemporary hydro-
genolysis of the benzyl ethers was carried out with Pd(OH)2 in
EtOH containing few drops of 5% aq. HCl to finally afford the
deprotected compound 7 in an almost quantitative yield.
In order to incorporate the obtained analogue into glycopep-
tides using either solution or solid phase synthesis, it would be
useful to maintain the azido group11 and to change the
protecting groups on the sugar moiety. The benzylated analogue
6 was thus submitted to acetolysis12 by treatment with
trimethylsilyl trifluoromethanesulfonate in Ac2O at room
temp. for 40 h to give the acetylated derivative 8 in 67%
yield.
§ 1H and 13C NMR spectra of compounds 6-8 each showed a single set of
peaks indicating the formation of a single diastereoisomer.
References
1 H. Lis and N. Sharon, Eur. J. Biochem., 1993, 218, 1; R. A. Dwek,
Chem. Rev., 1996, 96, 683; S.-I., Hakmori, Adv. Cancer Res., 1989, 52,
257; G. W. Hart, K. D. Greis, D. L.-Y. Dong, M. A. Blomberg, T.-Y.
Chou, M.-S. Jiang, E. P. Roquemore, D. M. Snow, L. K. Kreppel, R. N.
Cole, F. I. Comer, C. S. Arnold and B. K. Hayes, in Glycoimmunology,
ed. A. Alavi and J. S. Axford, Plenum Press, New York, 1995, pp. 115–
123.
2 J. F. Fisher, A. W. Harrison, G. L. Bundy, K. F. Wilkinson, B. D. Rush
and M. J. Ruwart, J. Med. Chem., 1991, 34, 3140; J. Kihlberg, J. Ahman,
B. Walse, T. Drakenberg, A Nilsson, C. So¨derberg-Ahlm, B. Bengtsson
and H. Olsson, J. Med. Chem., 1995, 38, 161.
3 K. Michael, V. Wittmann, W. Ko¨nig, J. Sandow and H. Kessler, Int.
J. Pept. Protein Res., 1996, 48, 59 and references cited therein.
4 B. J. Dorgan and R. F. W. Jackson, Synlett, 1996, 859.
5 A paper in which glucose is used in a Wittig rearrangement for the
stereoselective synthesis of chiral prop-2-ynylic alcohols has recently
been published: K. Tomooka, Y. Nakamura and T. Nakai, Synlett, 1995,
321.
6 K. Mikami, O. Takahashi, T. Tabei and T. Nakai, Tetrahedron Lett.,
1986, 27, 4511.
7 K. Kakinuma and H.-Y. Li, Tetrahedron Lett., 1989, 31, 4157.
8 I. Ohtani, T. Kusumi, Y. Kashman and H. Kakisawa, J. Am. Chem. Soc.,
1991, 113, 4092.
9 A. S. Thompson, G. R. Humphrey, A. M. DeMarco, D. J. Mathre and
E. J. J. Grabowski, J. Org. Chem., 1993, 58, 5886.
10 A. Bra¨ndstro¨m, B. Lamm and I. Palmertz, Acta Chem. Scand. Ser. B,
1974, 28, 699.
The 1H NMR spectrum of compound 8 showed a signal at d
3.42 due to the hydrogen atom at C-5 in which the coupling
constant with the adjacent ring hydrogen at C-6 (J 9.5 Hz)
clearly confirmed that the equatorial configuration had been
obtained at position 5, corresponding to the b-anomer of the
O-linked analogue.
The reported procedure allows a simple and stereoselective
access to the C-linked analogue of glucopyranosyl serine which
can be incorporated in synthetic peptides. As the sugar moiety
is not directly involved into chemical modifications, the
procedure could be, in principle, applicable to other mono-
saccharides. Work is in progress to extend the scope of the
procedure.
11 M. Meldal, M. A. Juliano and A. M. Jansson, Tetrahedron Lett., 1997,
38, 2531.
12 J. Alzeer and A. Vasella, Helv. Chim. Acta, 1995, 78, 177.
Part of the present work was supported by the EU-Carenet 2
program (ERB4061PL95-0372).
Received in Cambridge, UK, 6th May 1997; 7/03063K
1470
Chem. Commun., 1997